G3BP1 and cancer: Notably, G3BP1 KO cells display a higher level of PARP and caspase-3 cleavage upon morusin treatment compared to G3BP1 WT cells, suggesting that SG inhibition sensitizes the cancer cells to morusin (Figure 3A).